Opterion Health held its first Annual General Meeting at its new headquarters at The 5th Floor, in Muttenz, Baselland. The hybrid meeting was well attended by…
Name: Guido Grentzmann Role: Founder / CSO Guido Grentzmann founded Opterion in 2012 with the aim to develop a new solution for peritoneal dialysis that…
Name: Guido Grentzmann Role: Founder / CSO Guido Grentzmann founded Opterion in 2012 with the aim to develop a new solution for peritoneal dialysis that…
Yesterday, the new Opterion Health AG office in Muttenz, Baselland, was officially inaugurated and the entire team was overwhelmed to welcome so many guests, and…
Muttenz, Switzerland, 16 September 2021 – Opterion Health AG, a nephrology company focused on innovation in Peritoneal Dialysis (PD), today announced a significant strengthening of…
25 March 2021 – Opterion Health AG, a preclinical Swiss life science company, developing the first novel solution for peritoneal dialysis (PD) in the last…
6 February 2021 – “About 40% of dialysis incidence is due to diabetes. Further, in times of a pandemic, as we are currently experiencing, an…
19 January 2021 – Opterion Health AG, a preclinical Swiss life science company, developing the first novel solution for peritoneal dialysis (PD) in the last…